Invited lecture , Professor Gill’s teaper got best hepatology research paper award.
Outcomes Of Cifn And Rbv Therapy For Chronic Hep C G3 Patients Who Relapsed With Previous Peg-Interferon And Riba Therapy, 2010 Detail
Invited state of the art lecture on Management of Hepatorenal syndrome by (UEGW) United European gastroenterology week, Paris France October 22 2008.
Rapid Virological Response Is A Predictor Of Sustained Virological Response In Chronic Hep C G3 Patients Treated With Pegasys And Ribavirin, 2010Detail
Invited state of the art lecture on Hepatitis C treatment with Pegylated interferon, (APASAL), Asia pacific association of study of liver diseases Kyoto, Japan March 22 2007
Invited Lecture by United European Gastroenterology Society Berlin Germany, October 2006. Title: “Hepatitis C Asian Perspectives.
Invited lecture by International Symposium on Viral Hepatitis, Paris, France July 2, 2006. Title: Short Term Treatment of Hepatitis C Patients.
Invited lecture by European Association of Study of Liver Diseases (EASL) Vienna Austria on April 22nd, 2006. Title: ” Hepatitic C Treatment in Patients with Normal Liver Function Test
Invited Lecture of Hong Kong Society of Gastroenterology. Title: “Therapeutic Endoscopy New Trends.
Invited lecture by Turkish Society of gastroenterology in Istanbul Turkey on October 07, 2005. Title: “Variceal Bleed Management.
Invited lecture by Egyptian Society of Gastroenterology in September 2004 in Cairo, Egypt. Title: “Peptic Ulcer Disease Management.
Invited lecture at annual conference of Malaysian society of Gastroenterology in July 2004 in Kuala Lumpur. Title: “Hepatitis C Treatment New Trends.
TREATMENT OF CHRONIC HEPATITIS C GENOTYPE I PATIENTS ,MARCH 3RD 2012 28TH ANNUAL MEETING OF PAKISTAN SOCIETY OF GASTROENTEROLOGY IN KARACHI.
INVITED LECTURE , PAKISTAN MEDICAL ASSOCIATION JEHLUM MARCH 22 2012.TREATMENT CHALLENGES OF CHRONIC HEPATITIS CSINVILEASE
Invited lecture , Pakistan society of family physicians , Rawalpindi/Islamabad Chapter “Treatment challenges of chronic hepatitis C in Pakistan” April 14th 2011
Invited lecture , Pakistan society of gastroenterology annual conference , foundation university Rawalpindi “Functional bowel disorders” March 20th 2011
Invited lecture , Pakistan medical association , Jehlum chapter “Paradigm shift in Hepatitis C treatment” March 3rd 2011
Invited lecture , Nishtar medical college alumni association N-28 Silver jublee “Chronic hepatitis C treatment” Dec 24th 2010
Primary prevention of variceal bleed “Invited lecture for annual regional meeting of Pakistan Society for Study of Liver Diseases(PSSID) on April 4th 2010 at foundation university hospital Islamabd , Pakistan.”
Invited lecture on Hepatitis B and C co-infection management on 8th annual international conference of Gastroenterology and Hepatology in Faisalabad 25-26th july 2009
State of the art lecture on Management of Chronic Hepatitis B, PSSLD single topic conference April 12 2009 in Rawalpindi
State of the art lecture, Management of Hepatitis C, annual conference of (PSSLD) November 2007 Karachi.
State of the art lecture, annual conference of Pakistan society for study of liver diseases (PSSLD) Management of portal hypertension July 28, 2007 Karachi
State of the Art Lecture, in Pakistan Society of Gastroenterology Annual Conference in Karachi, March 2nd 2007. Title: “Hepatitis C Genotype IV Pakistani Perspectives”. Hepatitis C.
State of the Art Lecture, Annual Meeting of Pakistan Society of Gastroenterology, Hepatitis C. New avenues of Treatment, Mar 25, 2005.
Lecture Pakistan Institute of Medical Sciences (PIMS) Indication/Contra indication of Liver Transplantation, Mar 05, 2005.
Lecture Aga Khan University Hospital Karachi, Hepato-Renal Syndrome Mar 01, 2005.
Lecture, King Edward, Medical College, New Avenues of Treatment of Irritable bowl syndrome Feb 28, 2005
Lecture, Controversies, Asia Pacific Association of Study of Liver New Delhi India. Challenge in hepatitis C therapy, Dec 2004
Lecture, Asia Pacific Association of Study of Liver New Delhi India, Hepatitis C Treatment in Relapsers and on-responders, Dec 2004.
State of the Art Lecture Pakistan Society of Hepatology, a) Treatment of Hepatocellular Carcinoma. b) Management of Hepatitis B, Oct 2004.
Lecture, International Society of Quality of Life Research, Hong Kong meeting, Psychological Impact of Hepatitis C Diagnosis, Sep 25, 2004
State of the Art Lectures 19th Annual Congress of Pakistan, Society of Gastroenterology, a) Variceal Bleed Management, b) New Avenues of Treatment Irritable Bowl Syndrome. (IBS) c) New Avenue of Treatment of Hepatitis C Feb 30, 2004,
Lecture KRL Hospital Islamabad, Hepatitis C Management June 07, 2004.
Lecture Ayub Medical College Abbottabad, Controversies and Challenges in Hepatitis C Treatment May 05, 2004.
State of the Art Invited Lecture Infectious Disease Society of Pakistan. Ayub Medical College, Abbottabad, Controversies and Challenges in Hepatitis C Treatment, March, 2004
State of the Art Invited Lecture Quaid-e-Azam Medical College Bahawalpur, Management of Chronic Hepatitis B. Feb 2004
Pakistan Society of Oncology Medicine, Hepatocellular Carcinoma Treatment Challenges, Dec 2003.
Pakistan Society of Gastroenterology Annual Meeting, Current Treatment Challenges of Hepatitis C, June 15, 2003
Nishtar Medical College Multan Multan, Pakistan, State of the Art Lecture. NSAID Induced Gastropathy May 11, 2003
Annual Scientific Conference, Upper GI Bleed an Update, May 5.2003
Annual Scientific Conference of Pakistan Medical Association State of the Art Lectures RWP, H-Pylori Ulcers and Beyond May 04, 2003.
Lecture Pakistan Islamic Medical Association (PIMA) Annual Conference In Rawalpindi, Hepatitis B Up date, April 30, 2003.
Annual Scientific Session of Pakistan Society of Surgeons, State of the Art Lecture. Hepatocellular CA treatment Feb 22, 2003.
Annual Scientific Session of Pakistan Society of Surgeons, Lecture, Role of ERCP in Malignant obstructive Jaundice Feb 21, 2003
348th Annual Scientific Conference of Pakistan Medical Association Controversies/Challenges of hepatitis C, Dec 27 2002.
IGA is fully operational
Professor Gill and his team is seeing patients in person Observing and Practicing COVID-19 prevention guidelines Physicians rooms and waiting areas Are fully sanitized Patients and attendants are provided masks , gloves and sanitizer at the entry of the premises